GlassScriptPhysician profile
Jacqueline Messier
NPI 1356811384
$2,700.95
in general payments reported to CMS, 2019-2025
22 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,634 · 2022: $735 · 2023: $128 · 2024: $43.54 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $709.59 | 2021-2024 | |
| Sunovion Pharmaceuticals INC. | $305.38 | 2021 | |
| Lilly USA, LLC | $190.54 | 2021-2025 | Mounjaro, Zepbound |
| Ucb, INC. | $148.83 | 2021-2022 | |
| Allergan, INC. | $148.07 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $133.27 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $131.18 | 2021-2023 | Austedo |
| Alexion Pharmaceuticals, INC. | $117.49 | 2022 | |
| Novartis Pharmaceuticals Corporation | $110.54 | 2021-2022 | |
| Csl Behring | $100.33 | 2021-2022 | |
| Genzyme Corporation | $89.42 | 2022 | |
| Lundbeck LLC | $82.66 | 2021-2022 | |
| Biogen, INC. | $77.83 | 2021 | |
| Acadia Pharmaceuticals INC | $72.54 | 2021-2022 | |
| Phadia US INC. | $57.52 | 2023 | Immunocap |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $54.87 | 2021 | |
| Amgen INC. | $50.52 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $47.67 | 2021 | |
| Eisai INC. | $31.66 | 2022 | |
| Exact Sciences Corporation | $16.42 | 2025 | The Cologuard Plus Collection Kit |
| Nevro Corp. | $12.36 | 2022 | |
| Upsher-Smith Laboratories LLC | $12.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Messier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.